Why the study?
Does device-based diagnostic monitoring improve management and outcomes in heart failure patients?
Does device-based diagnostic monitoring improve management and outcomes in heart failure patients?
This review summarizes the evidence for utilizing diagnostic information from implanted cardiac rhythm management devices to monitor and manage heart failure patients.
Answers are grounded in this paper and cite their sources.
May support device diagnostics in HF management; leaves open whether routine use improves outcomes.
Heart failure (HF) is a complex and costly disease process associated with high morbidity and mortality. Implanted cardiac rhythm management devices are increasingly used in the HF population to provide therapies such as protection from sudden death and cardiac resynchronization therapy. Device-based diagnostic monitoring provides clinicians with information that can assist in identifying patients at risk for HF decompensation and subsequent hospitalization. This article will review the evidence for using diagnostic information from cardiac rhythm management devices in the management of HF patients. Future advanced monitoring devices will also be discussed.
No takes yet. Share an insight, caveat, or question.
Rathman et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: